BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21426070)

  • 1. Overview of computational methods employed in early-stage drug discovery.
    Skjevik AA; Teigen K; Martinez A
    Future Med Chem; 2009 Apr; 1(1):49-63. PubMed ID: 21426070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
    Campbell JB
    IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug discovery and the medicinal chemist.
    Maryanoff BE
    Future Med Chem; 2009 Apr; 1(1):11-5. PubMed ID: 21426067
    [No Abstract]   [Full Text] [Related]  

  • 4. Computational approach to de novo discovery of fragment binding for novel protein states.
    Konteatis ZD; Klon AE; Zou J; Meshkat S
    Methods Enzymol; 2011; 493():357-80. PubMed ID: 21371598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design and synthesis of libraries for the discovery of antibacterial and antifungal substances.
    Edwards PJ
    Drug Discov Today; 2011 Mar; 16(5-6):278-9. PubMed ID: 21277383
    [No Abstract]   [Full Text] [Related]  

  • 7. High-throughput methods for combinatorial drug discovery.
    Sun X; Vilar S; Tatonetti NP
    Sci Transl Med; 2013 Oct; 5(205):205rv1. PubMed ID: 24089409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Free-Wilson selectivity analysis for combinatorial library design.
    Sciabola S; Stanton RV; Johnson TL; Xi H
    Methods Mol Biol; 2011; 685():91-109. PubMed ID: 20981520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicinal chemistry inspired fragment-based drug discovery.
    Lanter J; Zhang X; Sui Z
    Methods Enzymol; 2011; 493():421-45. PubMed ID: 21371600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-assisted combinatorial chemistry: thermodynamics and kinetics in drug discovery.
    Cheeseman JD; Corbett AD; Gleason JL; Kazlauskas RJ
    Chemistry; 2005 Mar; 11(6):1708-16. PubMed ID: 15565741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening.
    Yi Mok N; Chadwick J; Kellett KA; Hooper NM; Johnson AP; Fishwick CW
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6770-4. PubMed ID: 19854048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications and limitations of in silico models in drug discovery.
    Sacan A; Ekins S; Kortagere S
    Methods Mol Biol; 2012; 910():87-124. PubMed ID: 22821594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug discovery and natural products: end of an era or an endless frontier?
    Li JW; Vederas JC
    Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current parallel chemistry principles and practice: application to the discovery of biologically active molecules.
    Edwards PJ
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):899-914. PubMed ID: 19894197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput virtual screening for drug discovery in parallel.
    Toledo-Sherman LM; Chen D
    Curr Opin Drug Discov Devel; 2002 May; 5(3):414-21. PubMed ID: 12058617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From purified GPCRs to drug discovery: the promise of protein-based methodologies.
    Alkhalfioui F; Magnin T; Wagner R
    Curr Opin Pharmacol; 2009 Oct; 9(5):629-35. PubMed ID: 19443270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling and enhanced molecular dynamics to steer structure-based drug discovery.
    Kalyaanamoorthy S; Chen YP
    Prog Biophys Mol Biol; 2014 May; 114(3):123-36. PubMed ID: 23827463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial library design from reagent pharmacophore fingerprints.
    Chen H; Engkvist O; Blomberg N
    Methods Mol Biol; 2011; 685():135-52. PubMed ID: 20981522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular library design using multi-objective optimization methods.
    Nicolaou CA; Kannas CC
    Methods Mol Biol; 2011; 685():53-69. PubMed ID: 20981518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of potent inhibitors of soluble epoxide hydrolase by combinatorial library design and structure-based virtual screening.
    Xing L; McDonald JJ; Kolodziej SA; Kurumbail RG; Williams JM; Warren CJ; O'Neal JM; Skepner JE; Roberds SL
    J Med Chem; 2011 Mar; 54(5):1211-22. PubMed ID: 21302953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.